AI governance in a GDP/GxP environment is not a single policy document — it is a set of interlocking practices covering validation and oversight of AI-assisted workflows, control of unsanctioned (“shadow”) AI use, clear policy for staff, appropriate limits on consumer-grade AI tools, and awareness of compliance risks that are easy to miss until they surface in an audit finding or deviation.
This section exists because pharma logistics teams are adopting AI faster than most governance frameworks are being written. The workflows described elsewhere in this playbook — excursion investigation, carrier risk assessment, audit preparation — all assume a governance layer sits underneath them. This section is that layer.
What’s Covered
- AI Governance: Validation and Oversight — What “validating” an AI-assisted workflow actually means in a GDP context, and where human oversight cannot be delegated.
- AI Governance: Shadow AI Risks — How unsanctioned AI tool use creeps into logistics and quality teams, and what it puts at risk.
- AI Policy Template — A starting-point structure for an internal AI use policy for logistics and quality teams.
- AI Governance: Consumer AI Limitations — Why consumer-tier AI tools carry different risk than enterprise-tier tools, and where the line should be drawn.
- AI Governance: Hidden Compliance Risks — Compliance risks that don’t show up until an audit, inspection, or investigation surfaces them.
Who This Is For
QA and compliance leaders building or updating an internal AI use policy; distribution and logistics managers deciding which AI tools their teams can use for which tasks; and anyone accountable for what happens when an AI-assisted workflow output ends up in front of an auditor.
Last updated August 7, 2026
